Market Overview

My goal is to be on stage with my computer and let you
see my screen and make sure you know what buttons to
press, where you’re getting in & out, how to calculate
risk, your targets — all of those things.
It’s real-life trading. Make sure you sign up!
- Jerremy Newsome
GET TICKETS

DDW 2019: New Study Shows SonarMD Lowers Cost of Managing Crohn's Disease

Share:

When people with Crohn's disease worked together with their
gastroenterologists to detect and address worsening symptoms sooner –
using SonarMD's care coordination solution – they were more likely to
stay out of the hospital. This reduced the annual medical cost for each
person by $6,500, according to research presented today at Digestive
Disease Week® (DDW) 2019 in San Diego.

This study was the result of a research partnership between SonarMD and
Blue Cross and Blue Shield of Illinois. In the 24-month cohort study,
researchers compared a group of 176 Crohn's disease patients who were
enrolled in SonarMD's solution to a matched control group that was not.

"Those savings come from avoided hospitalizations and outpatient
visits," said Dr. Lawrence Kosinski, a practicing gastroenterologist and
SonarMD's founder and CMO. "This study proves that SonarMD's care
coordination solution can lead to significant cost savings for patient
populations with high-beta conditions, like Crohn's disease."

High-beta conditions are symptomatic, chronic, and likely to deteriorate
rapidly – leading to complications, hospitalizations and highly variable
per capita costs. These conditions are often treated with high-cost
therapeutics, such as specialty drugs.

"SonarMD is starting in inflammatory bowel disease, but our solution
could easily expand into other high-beta conditions where there's room
to improve on care, cost, and outcomes," added Dr. Kosinski.

SonarMD contracts with payers to work directly with sub-specialists in
their network to provide value-based care for patients with high-beta
conditions.

"The results of this research study demonstrate how an innovative
approach to patient engagement and monitoring can improve access to
care, health outcomes and affordability," said Dr. Derek Robinson, vice
president and chief medical officer, Blue Cross and Blue Shield of
Illinois. "We're inspired by the study's positive results and will
continue to support value creating solutions that help patients achieve
their best possible state of health."

SonarMD's clinical staff uses technology to connect with patients,
calculate risk, and coordinate care. SonarMD regularly pings patients
with clinical questions they can respond to via text, email or phone
call. Using those responses, SonarMD calculates a Sonar Score that
correlates with symptom intensity. SonarMD tracks the score over time to
determine which patients are at risk of deteriorating and then work with
the patient's care team to intervene when necessary.

"As a Crohn's patient, I don't always recognize when my body is trying
to tell me something because I think my symptoms are just par for the
course," said Tami Speten, a patient who uses SonarMD. "I was once
called into my gastroenterologist's office because of my Sonar Score. We
quickly learned my blood and iron counts were dangerously low. I had no
idea I was so sick. If it weren't for SonarMD, I would have most likely
ended up in the hospital. This technology really helps to guide me
through my illness and has strengthened my relationship with my doctor."

NOTE TO REPORTERS ATTENDING DDW:

Session Title: Inflammatory Bowel Disease I
Session Sponsor: AGA
Session
Date and Time: May 19, 2019 from 12:00 PM to 2:00 PM
Presentation
Title: REDUCTION IN COSTS OF CARE IN PATIENTS WITH CROHN'S DISEASE IN A
COMMUNITY PRACTICE-BASED MEDICAL HOME OVER TWO YEARS: A PROPENSITY SCORE
MATCHED COHORT ANALYSIS
Poster Number: Su1786

About SonarMD

SonarMD is a care coordination and therapeutic optimization solution for
high-beta conditions. SonarMD's clinical staff and technology make it
easier for patients and specialists to work together to detect and
address worsening symptoms sooner and make the right
treatment decisions. The company contracts with payers and works
directly with sub-specialists in their network to provide value-based
care. SonarMD is starting in inflammatory bowel disease where it has
proven to reduce hospitalizations, saving health plans more than 15% per
member per year. For more information, visit www.SonarMD.com
and engage with SonarMD on LinkedIn
and Twitter.

About Digestive Disease Week®

Digestive Disease Week® (DDW) is the largest international gathering of
physicians, researchers and academics in the fields of gastroenterology,
hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by
the American Association for the Study of Liver Diseases (AASLD), the
American Gastroenterological Association (AGA) Institute, the American
Society for Gastrointestinal Endoscopy (ASGE) and the Society for
Surgery of the Alimentary Tract (SSAT), DDW takes place May 18-21, 2019,
at the San Diego Convention Center. The meeting showcases more than
5,000 abstracts and hundreds of lectures on the latest advances in GI
research, medicine and technology. More information can be found at www.ddw.org.

View Comments and Join the Discussion!
 
Lightning Fast
Market News Service
$199 Free 14 Day Trial